Northwestern scientists have determined how two protein mutations responsible for the impaired motor function in Parkinson’s disease independently disrupt neuron activity.
Combining the current standard-of-care chemotherapy drug with a genetic inhibitor may improve treatment for pancreatic ductal adenocarcinoma, according to a recent study published in PNAS.
Feinberg investigators are breaking down the mechanisms of aging and designing solutions to extend healthy living.
A cell-surface protein is essential for proper microcircuit function in the brain, according to a study published in Nature Communications.
During a recent webinar, Elizabeth McNally, MD, PhD, the Elizabeth J. Ward Professor of Genetic Medicine and director of the Center for Genetic Medicine, discussed findings from the ongoing Screening for Coronavirus Antibodies in Neighborhoods (SCAN) study and what genetics can reveal about COVID-19.
A viral protein of the Epstein-Barr virus previously thought to mimic immune cell receptor signaling actually rewires intracellular signaling in infected cells, promoting viral cell survival and proliferation.
Astrocytes may play a protective role in Parkinson’s disease, slowing alpha-synuclein accumulation in neurons, according to a study published in The Journal of Neuroscience.
Nathan Shlobin, a second-year medical student, was the first author of a study recently published in the Journal of Neurosurgery, which identified through systematic review potential risk factors for spinal cord ischemia related to anterior thoracolumbar surgery.
A newly discovered function of an epigenetic regulator could be a key to new cancer treatments, according to a new study published in Genes and Development.
A novel drug may improve the efficacy of corticosteroid treatment for patients with Duchenne muscular dystrophy and overall quality of life, according to a recent clinical trial.